Pfizer Inc (PFE)
28.09
-0.21
(-0.74%)
USD |
NYSE |
Nov 01, 16:00
28.10
+0.01
(+0.04%)
After-Hours: 20:00
Pfizer Price to Book Value: 1.815 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.815 |
| October 31, 2024 | 1.829 |
| October 30, 2024 | 1.843 |
| October 29, 2024 | 1.839 |
| October 28, 2024 | 1.865 |
| October 25, 2024 | 1.838 |
| October 24, 2024 | 1.851 |
| October 23, 2024 | 1.865 |
| October 22, 2024 | 1.864 |
| October 21, 2024 | 1.869 |
| October 18, 2024 | 1.888 |
| October 17, 2024 | 1.891 |
| October 16, 2024 | 1.917 |
| October 15, 2024 | 1.902 |
| October 14, 2024 | 1.879 |
| October 11, 2024 | 1.884 |
| October 10, 2024 | 1.896 |
| October 09, 2024 | 1.951 |
| October 08, 2024 | 1.886 |
| October 07, 2024 | 1.887 |
| October 04, 2024 | 1.847 |
| October 03, 2024 | 1.831 |
| October 02, 2024 | 1.849 |
| October 01, 2024 | 1.852 |
| September 30, 2024 | 1.870 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.880 |
| September 26, 2024 | 1.872 |
| September 25, 2024 | 1.869 |
| September 24, 2024 | 1.906 |
| September 23, 2024 | 1.894 |
| September 20, 2024 | 1.901 |
| September 19, 2024 | 1.916 |
| September 18, 2024 | 1.922 |
| September 17, 2024 | 1.928 |
| September 16, 2024 | 1.943 |
| September 13, 2024 | 1.891 |
| September 12, 2024 | 1.884 |
| September 11, 2024 | 1.916 |
| September 10, 2024 | 1.922 |
| September 09, 2024 | 1.900 |
| September 06, 2024 | 1.845 |
| September 05, 2024 | 1.842 |
| September 04, 2024 | 1.834 |
| September 03, 2024 | 1.829 |
| August 30, 2024 | 1.874 |
| August 29, 2024 | 1.856 |
| August 28, 2024 | 1.858 |
| August 27, 2024 | 1.862 |
| August 26, 2024 | 1.869 |
| August 23, 2024 | 1.867 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.764
Average
2.974
Median
Price to Book Value Benchmarks
| Amgen Inc | 22.80 |
| Johnson & Johnson | 5.495 |
| Eli Lilly and Co | 54.59 |
| Viking Therapeutics Inc | 8.910 |
| Moderna Inc | 1.793 |
Price to Book Value Related Metrics
| PE Ratio | 37.96 |
| PS Ratio | 2.657 |
| Price | 28.09 |
| Earnings Yield | 2.63% |
| Market Cap | 159.18B |
| Operating PE Ratio | 16.33 |
| Normalized PE Ratio | 18.10 |